Skip to Content

There Is a Lack of Data on the Effect of Dose Optimization

In practice, dose adjustments are frequently implemented to enhance treatment efficacy. However, robust evidence supporting the effectiveness of these modifications is often lacking, says Dr. Peter Bossuyt in this MEDtalk. At ECCO 2025, Dr. Bossuyt presented the REScUE study, which examined ustekinumab dose optimization in Crohn’s disease patients experiencing secondary loss of response.

Peter Bossuyt

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top